JPS6225360B2 - - Google Patents
Info
- Publication number
- JPS6225360B2 JPS6225360B2 JP396879A JP396879A JPS6225360B2 JP S6225360 B2 JPS6225360 B2 JP S6225360B2 JP 396879 A JP396879 A JP 396879A JP 396879 A JP396879 A JP 396879A JP S6225360 B2 JPS6225360 B2 JP S6225360B2
- Authority
- JP
- Japan
- Prior art keywords
- glutamyl
- substrate
- gtp
- solution
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000758 substrate Substances 0.000 claims description 25
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- RUKJCCIJLIMGEP-ONEGZZNKSA-N 4-dimethylaminocinnamaldehyde Chemical compound CN(C)C1=CC=C(\C=C\C=O)C=C1 RUKJCCIJLIMGEP-ONEGZZNKSA-N 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 125000001992 L-gamma-glutamyl group Chemical group N[C@@H](CCC(=O)*)C(=O)O 0.000 claims description 2
- 125000002642 gamma-glutamyl group Chemical group 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 235000019833 protease Nutrition 0.000 claims 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 238000005259 measurement Methods 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012089 stop solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 150000003931 anilides Chemical class 0.000 description 4
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- HSMNQINEKMPTIC-UHFFFAOYSA-N N-(4-aminobenzoyl)glycine Chemical compound NC1=CC=C(C(=O)NCC(O)=O)C=C1 HSMNQINEKMPTIC-UHFFFAOYSA-N 0.000 description 3
- 229960004567 aminohippuric acid Drugs 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- WMZTYIRRBCGARG-VIFPVBQESA-N (2s)-2-azaniumyl-5-(4-nitroanilino)-5-oxopentanoate Chemical compound OC(=O)[C@@H](N)CCC(=O)NC1=CC=C([N+]([O-])=O)C=C1 WMZTYIRRBCGARG-VIFPVBQESA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical group NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 2
- VOZOQWOUOOVFSB-UHFFFAOYSA-N 6-(trifluoromethyl)-2h-isoquinolin-1-one Chemical compound C1=CNC(=O)C=2C1=CC(C(F)(F)F)=CC=2 VOZOQWOUOOVFSB-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010008488 Glycylglycine Proteins 0.000 description 2
- 229960004909 aminosalicylic acid Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940043257 glycylglycine Drugs 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- VMNRUJGOLBSEPK-VIFPVBQESA-N N(5)-phenyl-L-glutamine zwitterion Chemical compound OC(=O)[C@@H](N)CCC(=O)NC1=CC=CC=C1 VMNRUJGOLBSEPK-VIFPVBQESA-N 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
[産業上の利用分野]
本発明は、γ−グルタミルアニリドに置換基を
導入した新規化合物を基質として使用するγ−グ
ルタミルトランスペプチターゼ(以下γ−GTP
と略記)定量用試薬に関するものである。
[従来の技術]
γ−GTPは生体内でグルタチオンや他のγ−
グルタミルペプチドからγ−グルタミル基をアミ
ノ酸、ペプチドなどの受容体に転移する酵素で
肝、腎、膵などの各臓器に多く存在する。臨床的
には閉塞性黄疸、慢性活動性肝炎、肝癌、アルコ
ール性肝炎などの肝臓疾患にγ−GTP活性の上
昇がみられ、その上昇にはγ−GTPの胆道系へ
の排泄障害による血中への移行と慢性活動性病変
による障害肝組織における生成亢進などの関係が
あると言われている。従つて、γ−GTP活性測
定は肝臓疾患の診断用として今日臨床検査室でま
すます実施されるようになつている。
従来、γ−GTP定量測定するための基質とし
てはL−γ−グルタミル−p−ニトロアニリドが
一般的に使用されてきたが、この場合基質溶解性
に重大な欠点があることは周知である。そこで通
常は基質の溶解に希塩酸や界面活性剤及び有機溶
媒を添加することによつてこの欠点を解決してい
る。〔特開昭52−29799〕
[発明が解決しようとする問題点]
しかし、この場合でも基質溶解後の自己分解や
界面活性剤の添加により生ずる気泡のために安定
性が極めて悪い。それ故、L−γ−グルタミル−
p−ニトロアニリドと比べて水によく溶ける良好
な基質を新規に製造することが上記の欠点を解決
するうえで望まれている。特開昭49−86338の記
載にみられるγ−GTP測定用の基質はカルボキ
シル基をp−ニトロアニリンの3位に導入して得
たL−γ−グルタミル−3−カルボキシ−4−ニ
トロアニリドやスルホン酸をp−ニトロアニリン
の3位に導入してL−γ−グルタミル−3−スル
ホン酸−4−ニトロアニリドを得ることにより溶
解性を高めることができたとのべている。ところ
が、この基質は初速度分析法を利用した自動分析
には適しているが、一般的に実施されている比色
測定では測定波長400nm前後を用いる必要があ
るため生体に存在するビリルビン等の影響をうけ
るため適さない。そこで、γ−GTP活性定量測
定のための一般的な使用に適した溶解性の良好な
基質の開発が依然として望まれるところである。
[問題点を解決するための手段]
本発明者は、かかる問題点を解決するために研
究した結果L−γ−グルタミルアニリドに置換基
を導入した種々の化合物中から溶解性の優れたγ
−GTP定量測定用の新規化合物を見出した。即
ち本発明は、下記〔〕又は〔〕における構造
式
(式中、RはL−γ−グルタミル基:
[Industrial Application Field] The present invention relates to γ-glutamyl transpeptidase (hereinafter referred to as γ-GTP) which uses a novel compound in which a substituent is introduced into γ-glutamylanilide as a substrate.
(abbreviated as )) relates to quantitative reagents. [Prior art] γ-GTP is converted into glutathione and other γ-GTP in vivo.
It is an enzyme that transfers the γ-glutamyl group from glutamyl peptide to receptors for amino acids, peptides, etc., and is present in large amounts in various organs such as the liver, kidney, and pancreas. Clinically, increased γ-GTP activity is observed in liver diseases such as obstructive jaundice, chronic active hepatitis, liver cancer, and alcoholic hepatitis. It is said that there is a relationship between the transition to the liver and increased production in liver tissues damaged by chronic active lesions. Therefore, gamma-GTP activity measurements are now increasingly being performed in clinical laboratories for the diagnosis of liver diseases. Conventionally, L-γ-glutamyl-p-nitroanilide has been generally used as a substrate for quantitative measurement of γ-GTP, but it is well known that this has a serious drawback in substrate solubility. Therefore, this drawback is usually solved by adding dilute hydrochloric acid, a surfactant, and an organic solvent to dissolve the substrate. [JP-A-52-29799] [Problems to be Solved by the Invention] However, even in this case, the stability is extremely poor due to self-decomposition after dissolving the substrate and bubbles generated due to the addition of a surfactant. Therefore, L-γ-glutamyl-
In order to overcome the above-mentioned drawbacks, it is desired to produce a new substrate that is more soluble in water than p-nitroanilide. The substrate for γ-GTP measurement described in JP-A No. 49-86338 is L-γ-glutamyl-3-carboxy-4-nitroanilide obtained by introducing a carboxyl group into the 3-position of p-nitroaniline. It is stated that solubility could be improved by introducing sulfonic acid into the 3-position of p-nitroaniline to obtain L-γ-glutamyl-3-sulfonic acid-4-nitroanilide. However, although this substrate is suitable for automatic analysis using the initial velocity analysis method, commonly performed colorimetric measurements require the use of a measurement wavelength of around 400 nm, which may be affected by bilirubin, etc., present in living organisms. Not suitable for receiving. Therefore, it is still desired to develop a substrate with good solubility that is suitable for general use for quantitative measurement of γ-GTP activity. [Means for Solving the Problems] As a result of research to solve the problems, the present inventor selected γ with excellent solubility from various compounds in which substituents were introduced into L-γ-glutamylanilide.
-A new compound for quantitative measurement of GTP was discovered. That is, the present invention relates to the following structural formula [] or [] (In the formula, R is L-γ-glutamyl group:
【式】を表わす。)
で表わされる化合物を基質として使用することを
特徴とするγ−GTP定量用試薬である。
本発明による基質はL−γ−グルタミルアニリ
ドに置換基を導入することを特徴とする。詳しく
は、L−γ−グルタミルアニリドにカルボキシル
基及び水酸基を導入したものとL−γ−グルタミ
ル−4−カルボキシアニリドにグリシンをアミド
結合したものである。このようにして得られる新
規化合物はL−γ−グルタミル−3−ヒドロキシ
−4−カルボキシアニリド又はL−γ−グルタミ
ル−4−カルボキシグリシンアミドアニリドであ
る。
本発明のγ−GTP定量用試薬は、上記基質及
びγ−GTPの酵素作用で基質から生成するp−
アミノサリチル酸又はp−アミノ馬尿酸を呈色さ
せるp−ジメチルアミノシンナムアルデヒドの発
色剤から基本的に構成される。
本発明による基質は、従来のγ−グルタミル−
p−ニトロアニリドの欠点を見事に解消できる。
即ち、γ−GTP定量において必要とされる基質
最適濃度が約6〜7mMに対して従来は約3〜4
mMの溶解度であつたが本発明では溶解剤なしで
水に15mMの濃度以上でも溶解可能である。
以下、本発明による基質の溶解性とγ−GTP
による基質の分解速度を第1表に示す。分解速度
はL−γ−グルタミル−p−ニトロアニリドを用
いた場合を100とした時の相対値で示した。(測定
条件は37℃15分である。)Represents [formula]. ) This is a reagent for quantifying γ-GTP, which is characterized by using a compound represented by the following as a substrate. The substrate according to the present invention is characterized in that a substituent is introduced into L-γ-glutamylanilide. Specifically, they are L-γ-glutamylanilide with a carboxyl group and a hydroxyl group introduced, and L-γ-glutamyl-4-carboxyanilide with glycine amide bonded. The novel compound thus obtained is L-γ-glutamyl-3-hydroxy-4-carboxyanilide or L-γ-glutamyl-4-carboxyglycinamide anilide. The reagent for quantifying γ-GTP of the present invention comprises the above-mentioned substrate and p-GTP generated from the substrate through the enzymatic action of γ-GTP.
It is basically composed of a color former of p-dimethylaminocinnamaldehyde which gives color to aminosalicylic acid or p-aminohippuric acid. The substrate according to the invention is a conventional γ-glutamyl-
The drawbacks of p-nitroanilide can be successfully overcome.
That is, the optimal substrate concentration required for γ-GTP quantification is about 6-7mM, whereas conventionally it is about 3-4mM.
The solubility was 15 mM, but in the present invention, it can be dissolved in water at a concentration of 15 mM or more without a solubilizing agent. Below, the solubility of the substrate according to the present invention and γ-GTP
Table 1 shows the decomposition rates of the substrates. The decomposition rate was expressed as a relative value when L-γ-glutamyl-p-nitroanilide was used as 100. (Measurement conditions are 37℃ for 15 minutes.)
【表】【table】
【表】
[作用]
本発明は、従来の基質と十分に置き換えられる
ことが可能である。得られる利点は100ミリモ
ル以上の基質溶液が調製できる。水に対して極
めて溶け易く従つて溶解剤の添加を必要としな
い。酵素による基質分解率が高い。一般に使
用されている比色測定に適しているなどを提供す
ることができる。
以下、実施例により本発明による基質を用いた
時のγ−GTP活性を定量するための試薬の調製
を説明する。
実施例 1
L−γ−グルタミル−3−ヒドロキシ−4−カ
ルボキシアニリドの製法
p−アミノサリチル酸8.1g(57.9ミリモル)
とフタロイル−L−グルタミン酸無水物15.0g
(58.0ミリモル)に無水ジオキサン150mlを加えて
65℃で1時間撹拌する。次いで減圧留去して、メ
タノール(250ml)に溶解させて80%ヒドラジン
水和物でPH9.0にする。室温にて24時間放置す
る。結晶を濾取して1N−HCl(100ml)に懸濁さ
せて不溶物を除き、濾液を2N−NH4OHでPH7.0に
し減圧留去する。残渣にはアセトンを加えて結晶
化させてエタノールで洗い減圧乾燥すると目的物
が10.2g(理論値の62.4%)得られる。
融点212−214℃(分解)、〔α〕18 0=+17.2(C
=0.5、1N−HCl)
実施例 2
L−γ−グルタミル−4−カルボキシグリシン
アミドアニリドの製法
p−アミノ馬尿酸10.0g(51.5ミリモル)とフ
タロイル−L−グルタミン酸無水物14.6g(56.7
ミリモル)に無水ジオキサン150mlを加えて60℃
で1時間撹拌する。次いで減圧留去してフタロイ
ル−L−γ−グルタミル−4−カルボキシグリシ
ンアミドアニリドの油状物を得た。この油状物を
メタノール(250ml)に溶解させて80%ヒドラジ
ン水和物でPH9.0にする。室温にて2日放置す
る。結晶を濾取して冷水、エタノールで洗い乾燥
する。0.5N−HCl(200ml)を加えて室温で30分
激しく撹拌し不溶物を除いて濾液を1N−Na2CO3
でPH7.0にする。これを減圧濃縮して残渣にアセ
トンを加えると目的とする化合物が9.0g(理論
値の54%)得られる。
融点244−246℃(分解)、〔α〕20 0=+18.6(C
=1.0、1N−HCl)
実施例 3
γ−GTP定量用試薬
(1) 試薬調製
L−γ−グルタミル−3−ヒドロキシ−4
−カルボキシアニリド2.27g、トリス(ヒド
ロキシメチル)アミノメタン6.05g及びグリ
シルグリシン11.88gを精製水で溶解しPH8.3
〜8.4に調製した後、全量1000mlとしたもの
を基質液とする。
p−ジメチルアミノシンナムアルデヒド
900mgをエタノール600mlに溶解させたのち、
精製水を加えて全量1000mlとしたものを発色
液とする。
0.3N塩酸を反応停止液とする。
発色液と反応停止液とを2:1の割で混合
して混合液を作る。
5−アミノサリチル酸0.918gを15mM水
酸化ナトリウム液に溶かし全量1000mlとした
ものを標準液(400mU/ml)とする。
(2) 定量方法
血清を1/5〜5/5まで生食で希釈し、その20μ
と基質液1mlを混合し、37℃で15分インキユ
ベーシヨンした後、発色液と反応停止液の混合
液3mlを添加する。5分放置後、試薬ブランク
を対照にして波長540nmで吸光度を測定す
る。この結果を第2表に示す。
実施例 4
γ−GTP定量用試薬
(1) 試薬調製
L−γ−グルタミル−4−カルボキシグリ
シンアミドアニリド1.97g、トリス(ヒドロ
キシメチル)アミノメタン6.05g及びグリシ
ルグリシン11.88gを精製水で溶解しPH8.3〜
8.4に調製した後、全量1000mlとしたものを
基質液とする。
p−ジメチルアミノシンナムアルデヒド
900mgをエタノール600mlに溶解させたのち、
精製水を加えて全量1000mlとしたものを発色
液とする。
0.3N塩酸を反応停止液とする。
発色液と反応停止液とを2:1の割で混合
して混合液を作る。
p−アミノ馬尿酸1.164gを15mM水酸化
ナトリウム液に溶かし全量1000mlとしたもの
を標準液(400mU/ml)とする。
(2) 定量方法
実施例3−(2)と同様に操作する。その結果を
第3表に示す。[Table] [Effect] The present invention can fully replace conventional substrates. The advantage obtained is that substrate solutions of 100 mmol or more can be prepared. It is highly soluble in water and therefore does not require the addition of solubilizers. The rate of substrate decomposition by enzymes is high. Suitable for commonly used colorimetric measurements, etc. can be provided. Hereinafter, the preparation of a reagent for quantifying γ-GTP activity using the substrate according to the present invention will be explained with reference to Examples. Example 1 Process for producing L-γ-glutamyl-3-hydroxy-4-carboxyanilide p-aminosalicylic acid 8.1g (57.9 mmol)
and phthaloyl-L-glutamic anhydride 15.0g
(58.0 mmol) and add 150 ml of anhydrous dioxane.
Stir at 65°C for 1 hour. Then, it was distilled off under reduced pressure, dissolved in methanol (250 ml), and adjusted to pH 9.0 with 80% hydrazine hydrate. Leave at room temperature for 24 hours. The crystals were collected by filtration and suspended in 1N HCl (100 ml) to remove insoluble materials, and the filtrate was adjusted to pH 7.0 with 2N NH 4 OH and evaporated under reduced pressure. The residue is crystallized by adding acetone, washed with ethanol, and dried under reduced pressure to obtain 10.2 g (62.4% of theory) of the desired product. Melting point 212-214℃ (decomposition), [α] 180 = +17.2 (C
= 0.5, 1N-HCl) Example 2 Process for producing L-γ-glutamyl-4-carboxyglycinamide anilide 10.0 g (51.5 mmol) of p-aminohippuric acid and 14.6 g (56.7 mmol) of phthaloyl-L-glutamic anhydride
Add 150 ml of anhydrous dioxane to 60℃
Stir for 1 hour. Then, the residue was distilled off under reduced pressure to obtain an oily product of phthaloyl-L-γ-glutamyl-4-carboxyglycinamide anilide. Dissolve this oil in methanol (250 ml) and adjust the pH to 9.0 with 80% hydrazine hydrate. Leave at room temperature for 2 days. The crystals are collected by filtration, washed with cold water and ethanol, and dried. Add 0.5N-HCl (200ml), stir vigorously at room temperature for 30 minutes, remove insoluble matter, and dilute the filtrate with 1N-Na 2 CO 3
Set the pH to 7.0. This is concentrated under reduced pressure and acetone is added to the residue to obtain 9.0 g (54% of theory) of the target compound. Melting point 244-246℃ (decomposition), [α] 20 0 = +18.6 (C
= 1.0, 1N-HCl) Example 3 Reagent for quantifying γ-GTP (1) Reagent preparation L-γ-glutamyl-3-hydroxy-4
-Dissolve 2.27g of carboxyanilide, 6.05g of tris(hydroxymethyl)aminomethane and 11.88g of glycylglycine in purified water to reach a pH of 8.3.
~ After preparing in 8.4, the total volume was made to 1000 ml, and this was used as the substrate solution. p-dimethylaminocinnamaldehyde
After dissolving 900mg in 600ml of ethanol,
Add purified water to make a total volume of 1000ml and use it as the coloring solution. Use 0.3N hydrochloric acid as the reaction stop solution. A mixed solution is prepared by mixing a color developing solution and a reaction stop solution at a ratio of 2:1. A standard solution (400 mU/ml) is prepared by dissolving 0.918 g of 5-aminosalicylic acid in a 15 mM sodium hydroxide solution to make a total volume of 1000 ml. (2) Quantification method Dilute serum to 1/5 to 5/5 with normal saline, and dilute 20μ
After mixing 1 ml of the substrate solution and incubating at 37°C for 15 minutes, add 3 ml of a mixture of coloring solution and reaction stop solution. After standing for 5 minutes, absorbance is measured at a wavelength of 540 nm using a reagent blank as a control. The results are shown in Table 2. Example 4 Reagent for quantifying γ-GTP (1) Reagent preparation 1.97 g of L-γ-glutamyl-4-carboxyglycinamide anilide, 6.05 g of tris(hydroxymethyl)aminomethane, and 11.88 g of glycylglycine were dissolved in purified water. PH8.3~
After preparing in 8.4, make the total volume 1000ml and use it as the substrate solution. p-dimethylaminocinnamaldehyde
After dissolving 900mg in 600ml of ethanol,
Add purified water to make a total volume of 1000ml and use it as the coloring solution. Use 0.3N hydrochloric acid as the reaction stop solution. A mixed solution is prepared by mixing a color developing solution and a reaction stop solution at a ratio of 2:1. A standard solution (400 mU/ml) is prepared by dissolving 1.164 g of p-aminohippuric acid in 15 mM sodium hydroxide solution to a total volume of 1000 ml. (2) Quantification method Operate in the same manner as in Example 3-(2). The results are shown in Table 3.
【表】【table】
【表】【table】
Claims (1)
L−γ−グルタミルアニリドに置換基を導入した
基質及びp−ジメチルアミノシンナムアルデヒド
からなることを特徴とするγ−グルタミルトラン
スペプチダーゼ定量用試薬。 構造式 (式中、RはL−γ−グルタミル基:
【式】を表わす。)[Scope of Claims] 1. A γ-glutamyl trans characterized by comprising a substrate obtained by introducing a substituent into L-γ-glutamylanilide represented by the following structural formula [] or [], and p-dimethylaminocinnamaldehyde. Reagent for quantifying peptidase. Structural formula (In the formula, R is L-γ-glutamyl group:
Represents [formula]. )
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP396879A JPS5599199A (en) | 1979-01-19 | 1979-01-19 | Reagent for qualitative analysis of gamma-glutamyl transpeptidase and preparation of substrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP396879A JPS5599199A (en) | 1979-01-19 | 1979-01-19 | Reagent for qualitative analysis of gamma-glutamyl transpeptidase and preparation of substrate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25369786A Division JPS62171700A (en) | 1986-10-27 | 1986-10-27 | Substrate for determination gamma-glutamyltanspeptidase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5599199A JPS5599199A (en) | 1980-07-28 |
JPS6225360B2 true JPS6225360B2 (en) | 1987-06-02 |
Family
ID=11571866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP396879A Granted JPS5599199A (en) | 1979-01-19 | 1979-01-19 | Reagent for qualitative analysis of gamma-glutamyl transpeptidase and preparation of substrate |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5599199A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5623897A (en) * | 1979-08-07 | 1981-03-06 | Yatoron:Kk | Measurement of gamma-gtp activity by using novel substrate |
-
1979
- 1979-01-19 JP JP396879A patent/JPS5599199A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5599199A (en) | 1980-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4281181A (en) | Novel L-γ-glutamyl-3-carboxy-4-hydroxyanilide and salts thereof | |
EP0157326B1 (en) | Composition and test device for determining the presence of leukocytes, esterase and protease in a test sample | |
CA1311333C (en) | Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities | |
EP0034122A1 (en) | Tripeptide derivatives and their use in the determination of enzymes | |
JPS593475B2 (en) | Indoxyl-amino acid ester and -peptide ester, process for producing the compound, and diagnostic agent for detecting proteolytic enzymes containing the compound as a chromogen | |
JPH0550278B2 (en) | ||
US4716222A (en) | Substrates for hydrolases | |
US3979447A (en) | γ-Glutamyl-4-nitroanilide compounds | |
JPS6241710B2 (en) | ||
JPS6245227B2 (en) | ||
DE2801070A1 (en) | COLORIMETRIC PROCEDURE FOR THE DETERMINATION OF GAMMA-GLUTAMYL TRANSPEPTIDASE ENZYMACTIVITY | |
JPS631347B2 (en) | ||
US3986931A (en) | γ-GLUTAMYL-4-NITROANILIDE COMPOUNDS AND THEIR USE IN DETERMINING γ-GLUTAMYL TRANSPEPTIDASE | |
JPH0432835B2 (en) | ||
JPS6225360B2 (en) | ||
US4049702A (en) | γ-Glutamyl-4-nitroanilide compounds | |
JP3081016B2 (en) | Crystalline thionicotinamide-adenine dinucleotide potassium phosphate and process for producing the same | |
US20070111274A1 (en) | Water-soluble tetrazolium compounds | |
US4260681A (en) | Reagent system and method for assaying peptidase enzymes | |
DE3689171T2 (en) | WATER-SOLUBLE XANTHYLIUM BUTTERFLIES. | |
US4191809A (en) | Method of measuring enzymatic activity using novel peptide derivatives | |
JPS62171700A (en) | Substrate for determination gamma-glutamyltanspeptidase | |
JPH0215826B2 (en) | ||
US6528652B1 (en) | Composition and device for detecting leukocytes in urine | |
JP2583440B2 (en) | Substrate for measuring enzyme activity and method for measuring enzyme activity using the same |